Atrial Overdrive Pacing Could Benefit Some Sleep Apnea Sufferers – NEJM
This article was originally published in The Gray Sheet
Executive Summary
Atrial overdrive pacing will continue to play only a small role in the treatment of sleep apnea, Daniel Gottlieb, MD, Boston University predicts in a New England Journal of Medicine editorial
You may also be interested in...
Surprising CPAP Findings Should Not Discourage Development – NEJM
Manufacturers should continue to develop continuous positive airway pressure technology to improve cardiovascular outcomes, despite a new trial showing that the procedure does not improve mortality in heart failure patients with central sleep apnea, according to an editorial in the Nov. 10 New England Journal of Medicine.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.